GMT Capital’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163K Sell
42,421
-55,687
-57% -$228K 0.01% 74
2025
Q4
$364K Hold
98,108
0.02% 37
2025
Q3
$1.39M Hold
98,108
0.06% 49
2025
Q2
$1.88M Hold
98,108
0.08% 46
2025
Q1
$1.09M Sell
98,108
-6
-0% -$72 0.06% 55
2024
Q4
$1.63M Hold
98,114
0.08% 43
2024
Q3
$996K Hold
98,114
0.04% 55
2024
Q2
$5.67M Buy
+98,114
New +$4.81M 0.21% 32
2023
Q4
Sell
-36,052
Closed -$5.88M 79
2023
Q3
$5.88M Buy
+36,052
New +$8.51M 0.22% 50

Other funds holding OM

GMT Capital's OM Position: Q1 2026 in Review

GMT Capital reduced its Outset Medical (OM) stake by 57% in Q1 2026, selling an estimated $228K and leaving 42,421 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #74.

GMT Capital first reported a position in OM in Q3 2023 and has held it in 9 quarters since. The position peaked at $5.88M in Q3 2023. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • GMT Capital held 42,421 shares of Outset Medical worth $163K as of Q1 2026.
  • GMT Capital sold 55,687 Outset Medical shares in Q1 2026, an estimated $228K.
  • Outset Medical made up 0.01% of GMT Capital's portfolio in Q1 2026, its #74 holding.
  • GMT Capital first reported a position in Outset Medical in Q3 2023 and has held it in 9 quarters since.
  • GMT Capital's Outset Medical position peaked at $5.88M in Q3 2023.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on GMT Capital's 13F filing for Q1 2026, filed 15 May 2026.